ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,788,655 | +1.5% | 757,613 | +16.6% | 0.17% | +16.8% |
| Q2 2023 | $15,560,555 | +54.8% | 649,710 | +21.7% | 0.15% | +43.3% |
| Q1 2023 | $10,050,915 | +74.9% | 534,055 | +48.0% | 0.10% | +65.1% |
| Q4 2022 | $5,745,162 | -27.5% | 360,877 | -25.5% | 0.06% | -32.3% |
| Q3 2022 | $7,927,000 | -0.7% | 484,563 | -14.4% | 0.09% | +1.1% |
| Q2 2022 | $7,979,000 | -62.5% | 566,323 | -35.6% | 0.09% | -52.3% |
| Q1 2022 | $21,289,000 | -13.7% | 878,990 | -16.8% | 0.19% | -1.0% |
| Q4 2021 | $24,664,000 | +281.1% | 1,056,713 | +171.3% | 0.20% | +282.4% |
| Q3 2021 | $6,471,000 | -74.7% | 389,569 | -62.8% | 0.05% | -72.7% |
| Q2 2021 | $25,545,000 | +114.6% | 1,047,347 | +127.0% | 0.19% | +107.8% |
| Q1 2021 | $11,904,000 | -76.8% | 461,377 | -51.9% | 0.09% | -76.3% |
| Q4 2020 | $51,252,000 | +25.0% | 958,692 | -3.6% | 0.38% | +5.9% |
| Q3 2020 | $41,004,000 | -28.7% | 994,039 | -16.2% | 0.36% | -29.7% |
| Q2 2020 | $57,509,000 | +0.4% | 1,186,484 | -12.5% | 0.51% | -20.8% |
| Q1 2020 | $57,268,000 | +780.5% | 1,355,455 | +368.3% | 0.64% | +1268.1% |
| Q1 2018 | $6,504,000 | +146.2% | 289,443 | +229.9% | 0.05% | +147.4% |
| Q4 2017 | $2,642,000 | -82.7% | 87,734 | -78.4% | 0.02% | -82.7% |
| Q3 2017 | $15,314,000 | -18.3% | 406,521 | -39.5% | 0.11% | -19.7% |
| Q2 2017 | $18,734,000 | -14.3% | 671,709 | +5.7% | 0.14% | -14.9% |
| Q1 2017 | $21,855,000 | +102.2% | 635,688 | +69.6% | 0.16% | +94.0% |
| Q4 2016 | $10,811,000 | -46.4% | 374,873 | -40.8% | 0.08% | -48.4% |
| Q3 2016 | $20,158,000 | +129.0% | 633,690 | +133.6% | 0.16% | +123.6% |
| Q2 2016 | $8,804,000 | +11.6% | 271,231 | -3.9% | 0.07% | +14.3% |
| Q1 2016 | $7,890,000 | -35.9% | 282,199 | -18.3% | 0.06% | -38.2% |
| Q4 2015 | $12,313,000 | – | 345,384 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |